Your browser doesn't support javascript.
loading
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers.
Tuna, Musaffe; Ju, Zhenlin; Yoshihara, Kosuke; Amos, Christopher I; Tanyi, Janos L; Mills, Gordon B.
Affiliation
  • Tuna M; Department of Medicine, Baylor College of Medicine, Houston, TX, USA. mtuna9@gmail.com.
  • Ju Z; Precision Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. mtuna9@gmail.com.
  • Yoshihara K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Amos CI; Department of Obstetrics and Gynecology, Niigata University, Niigata, Japan.
  • Tanyi JL; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Mills GB; Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Br J Cancer ; 122(3): 405-412, 2020 02.
Article in En | MEDLINE | ID: mdl-31780779
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Tumor Suppressor Protein p53 / Carcinoma, Ovarian Epithelial Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Tumor Suppressor Protein p53 / Carcinoma, Ovarian Epithelial Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2020 Document type: Article Affiliation country: Country of publication: